{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:45:57Z","timestamp":1789994757684,"version":"4.0.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Institute for the promotion of Innovation by Science and Technology in Flanders (IWT)","award":["SBO-IWT"],"award-info":[{"award-number":["SBO-IWT"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.ejps.2014.11.010","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T07:31:10Z","timestamp":1416987070000},"page":"126-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Evaluation of fasted state human intestinal fluid as apical solvent system in the Caco-2 absorption model and comparison with FaSSIF"],"prefix":"10.1016","volume":"67","author":[{"given":"Benjamin","family":"Wuyts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Riethorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Annaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Augustijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2014.11.010_b0005","first-page":"97","article-title":"Influence of intestinal efflux pumps on the absorption and transport of furosemide","volume":"18","author":"Al-Mohizea","year":"2010","journal-title":"Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc."},{"key":"10.1016\/j.ejps.2014.11.010_b0010","first-page":"15","article-title":"Ex vivo permeability experiments in excised rat intestinal tissue and in vitro solubility measurements in aspirated human intestinal fluids support age-dependent oral drug absorption","volume":"39","author":"Annaert","year":"2010","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.11.010_b0015","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","article-title":"Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells","volume":"175","author":"Artursson","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2014.11.010_b0020","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1023\/A:1026402410783","article-title":"The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds","volume":"17","author":"Aungst","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.11.010_b0025","first-page":"386","article-title":"Accounting for the solubility\u2013permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorption","volume":"81","author":"Beig","year":"2012","journal-title":"Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft F\u00fcr Pharm. Verfahrenstechnik EV"},{"key":"10.1016\/j.ejps.2014.11.010_b0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF01061844","article-title":"Comparative pharmacokinetics of caffeine in young and elderly men","volume":"11","author":"Blanchard","year":"1983","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejps.2014.11.010_b0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/1568026013394886","article-title":"Strategies for absorption screening in drug discovery and development","volume":"1","author":"Bohets","year":"2001","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejps.2014.11.010_b0040","doi-asserted-by":"crossref","unstructured":"Brouwers, J., Augustijns, P., 2014. Resolving intraluminal drug and formulation behavior: gastrointestinal concentration profiling in humans. In: Eur. J. Pharm. Sci., Theme Issue 5th World Conference on Drug Absorption, Transport and Delivery 61, 2\u201310.","DOI":"10.1016\/j.ejps.2014.01.010"},{"key":"10.1016\/j.ejps.2014.11.010_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-198916010-00001","article-title":"Clinical pharmacokinetics of non-opiate abused drugs","volume":"16","author":"Busto","year":"1989","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2014.11.010_b0050","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.vascn.2010.02.004","article-title":"Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi design","volume":"61","author":"Chen","year":"2010","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejps.2014.11.010_b0055","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1365-2125.1997.00609.x","article-title":"Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers","volume":"43","author":"Cheymol","year":"1997","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2014.11.010_b0060","first-page":"260","article-title":"Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids","volume":"43","author":"Clarysse","year":"2011","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.11.010_b0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-3565(24)37939-X","article-title":"Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2","volume":"288","author":"Collett","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2014.11.010_b0070","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/jps.23494","article-title":"Designing a dynamic dissolution method: a review of instrumental options and corresponding physiology of stomach and small intestine","volume":"102","author":"Culen","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.11.010_b0075","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1208\/s12248-012-9337-6","article-title":"The solubility\u2013permeability interplay and its implications in formulation design and development for poorly soluble drugs","volume":"14","author":"Dahan","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2014.11.010_b0080","series-title":"Drug Absorption Studies, Biotechnology: Pharmaceutical Aspects","first-page":"182","article-title":"In Vitro Screening Models to Assess Intestinal Drug Absorption and Metabolism","author":"Deferme","year":"2008"},{"key":"10.1016\/j.ejps.2014.11.010_b0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2008.02.026","article-title":"Improved delivery of cromolyn from oral proliposomal beads","volume":"358","author":"Deshmukh","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.11.010_b0090","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gut.29.8.1035","article-title":"Measurement of gastrointestinal pH profiles in normal ambulant human subjects","volume":"29","author":"Evans","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.ejps.2014.11.010_b0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijpharm.2011.10.026","article-title":"Application of simulated intestinal fluid on the phospholipid vesicle-based drug permeation assay","volume":"422","author":"Fischer","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.11.010_b0100","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.2042-7158.2011.01301.x","article-title":"In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants","volume":"63","author":"Fischer","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2014.11.010_b0105","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2008.04.034","article-title":"Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs","volume":"360","author":"Fossati","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.11.010_b0110","first-page":"16","article-title":"Impact of FaSSIF on the solubility and dissolution-\/permeation rate of a poorly water-soluble compound","volume":"47","author":"Frank","year":"2012","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.11.010_b0115","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting in vivo performance of Class I and II Drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.11.010_b0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF01059645","article-title":"Gastrointestinal absorption of quinidine from some solutions and commercial tablets","volume":"8","author":"Guentert","year":"1980","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejps.2014.11.010_b0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-2275(20)35380-3","article-title":"Enzymatic measurement of choline-containing phospholipids in bile","volume":"22","author":"Gurantz","year":"1981","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejps.2014.11.010_b0130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00630286","article-title":"Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis","volume":"26","author":"Hammarlund","year":"1984","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2014.11.010_b0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6","article-title":"Caco-2 versus caco-2\/HT29-MTX co-cultured cell lines: Permeabilities via diffusion, inside- and outside-directed carrier-mediated transport","volume":"89","author":"Hilgendorf","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.11.010_b0140","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1023\/A:1015937605100","article-title":"Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa","volume":"7","author":"Hilgers","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.11.010_b0145","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1128\/AAC.42.11.2784","article-title":"Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers","volume":"42","author":"Hsu","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2014.11.010_b0150","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ijpharm.2012.10.025","article-title":"Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media","volume":"441","author":"Hu","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.11.010_b0155","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2004.01.014","article-title":"Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers","volume":"274","author":"Ingels","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.11.010_b0160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(01)00897-3","article-title":"Simulated intestinal fluid as transport medium in the Caco-2 cell culture model","volume":"232","author":"Ingels","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.11.010_b0165","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1248\/bpb.29.522","article-title":"Pharmacokinetic analysis of transcellular transport of quinidine across monolayers of human intestinal epithelial Caco-2 cells","volume":"29","author":"Ishida","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejps.2014.11.010_b0170","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000472513","article-title":"The absorption of doxorubicin and mitomycin C in perioperative instillation. An experimental and clinical study","volume":"11","author":"Jauhiainen","year":"1985","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejps.2014.11.010_b0175","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0169-409X(01)00115-6","article-title":"Drug transfer through mucus","volume":"48","author":"Khanvilkar","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2014.11.010_b0180","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3109\/00498254.2012.751140","article-title":"The limited intestinal absorption via paracellular pathway is responsible for the low oral bioavailability of doxorubicin","volume":"43","author":"Kim","year":"2013","journal-title":"Xenobiotica Fate Foreign Compd. Biol. Syst."},{"key":"10.1016\/j.ejps.2014.11.010_b0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003088-199835010-00002","article-title":"Clinical pharmacokinetics of vasodilators","volume":"35","author":"Kirsten","year":"1998","journal-title":"Part II Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2014.11.010_b0190","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF00637603","article-title":"Creation of four consecutive instantaneous steady-state plasma concentration plateaus of theophylline and enprofylline by repeated infusions with exponentially decreasing delivery rates","volume":"35","author":"Kraan","year":"1988","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2014.11.010_b0195","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1470-2045(00)00032-2","article-title":"Effect of the breast-cancer resistance protein on atypical multidrug resistance","volume":"1","author":"Lage","year":"2000","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejps.2014.11.010_b0200","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/js980474k","article-title":"Saturable transport of H2-antagonists ranitidine and famotidine across Caco-2 cell monolayers","volume":"88","author":"Lee","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.11.010_b0205","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1023\/A:1024406221962","article-title":"Modulation of nonspecific binding in ultrafiltration protein binding studies","volume":"20","author":"Lee","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.11.010_b0210","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/00498250701704819","article-title":"Intestinal permeability and its relevance for absorption and elimination","volume":"37","author":"Lennern\u00e4s","year":"2007","journal-title":"Xenobiotica Fate Foreign Compd. Biol. Syst."},{"key":"10.1016\/j.ejps.2014.11.010_b0215","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5173(95)04204-0","article-title":"Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo","volume":"127","author":"Lennern\u00e4s","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.11.010_b0220","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1023\/A:1026450326712","article-title":"Mechanisms of transport and structure\u2013permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers","volume":"17","author":"Liang","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.11.010_b0225","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/j.1552-4604.1987.tb03060.x","article-title":"The effects of a beta-2 selective adrenergic agonist and a beta-nonselective antagonist on theophylline clearance","volume":"27","author":"Lombardi","year":"1987","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2014.11.010_b0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2005.03.008","article-title":"Validation of the 96 well Caco-2 cell culture model for high throughput permeability assessment of discovery compounds","volume":"297","author":"Marino","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.11.010_b0235","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/cpt1979254408","article-title":"Kinetics and absolute bioavailability of atenolol","volume":"25","author":"Mason","year":"1979","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2014.11.010_b0240","doi-asserted-by":"crossref","first-page":"18131","DOI":"10.1073\/pnas.0606428103","article-title":"A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms","volume":"103","author":"Matsui","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2014.11.010_b0245","first-page":"167","article-title":"Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models","volume":"8","author":"Meaney","year":"1999","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.11.010_b0250","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/mp200181v","article-title":"The solubility\u2013permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation","volume":"8","author":"Miller","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2014.11.010_b0255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression \u2013 a new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ejps.2014.11.010_b0260","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1023\/A:1025032511040","article-title":"pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug\u2013drug interactions","volume":"20","author":"Neuhoff","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.11.010_b0265","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1023\/A:1012111008617","article-title":"Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model","volume":"14","author":"Pade","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.11.010_b0270","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1023\/A:1012188625088","article-title":"Polar molecular surface properties predict the intestinal absorption of drugs in humans","volume":"14","author":"Palm","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.11.010_b0275","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01061407","article-title":"Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man","volume":"2","author":"Reg\u00e5rdh","year":"1974","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejps.2014.11.010_b0280","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/jps.1127","article-title":"Effect of common excipients on Caco-2 transport of low-permeability drugs","volume":"90","author":"Rege","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.11.010_b0285","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1128\/AEM.43.6.1451-1463.1982","article-title":"Microbial flora of the mouse ileum mucous layer and epithelial surface","volume":"43","author":"Rozee","year":"1982","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ejps.2014.11.010_b0290","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/BF00210000","article-title":"Luminal mucin in the large intestine of mice, rats and guinea pigs","volume":"219","author":"Sakata","year":"1981","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejps.2014.11.010_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","article-title":"The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics","volume":"21","author":"Sambuy","year":"2005","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ejps.2014.11.010_b0300","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/BIR-1987-24614","article-title":"Mechanical characterization and properties of gastrointestinal mucus gel","volume":"24","author":"Sellers","year":"1986","journal-title":"Biorheology"},{"issue":"Suppl 1","key":"10.1016\/j.ejps.2014.11.010_b0305","first-page":"101","article-title":"Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine)","volume":"30","author":"Smetanova","year":"2009","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.ejps.2014.11.010_b0310","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0090-9556(25)00282-X","article-title":"Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay","volume":"8","author":"Smith","year":"1980","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"10.1016\/j.ejps.2014.11.010_b0315","first-page":"250","article-title":"Formulation and evaluation of transdermal patches of carvedilol","volume":"6","author":"Sowjanya","year":"2013","journal-title":"J. Chem. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.11.010_b0320","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/10409239209082559","article-title":"Mucin-type glycoproteins","volume":"27","author":"Strous","year":"1992","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.ejps.2014.11.010_b0325","first-page":"206","article-title":"Absorption of drugs from the human jejunum and ileum","author":"Sutcliffe","year":"1988","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2014.11.010_b0330","unstructured":"U.S. Food and Drug Administration, 2011. Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers [WWW Document]. <http:\/\/www.fda.gov\/drugs\/developmentapprovalprocess\/developmentresources\/druginteractionslabeling\/ucm093664.htm#PgpTransport> (accessed 28.09.14)."},{"key":"10.1016\/j.ejps.2014.11.010_b0335","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0022-5347(25)00231-9","article-title":"Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolites","volume":"241","author":"Walle","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2014.11.010_b0340","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1008192010023","article-title":"Lipophilicity in PK design: methyl, ethyl, futile","volume":"15","author":"Waterbeemd","year":"2001","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejps.2014.11.010_b0345","first-page":"195","article-title":"Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells","volume":"10","author":"Yamashita","year":"2000","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.11.010_b0350","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/bdd.2510030305","article-title":"Effect of sustained release on the pharmacokinetic profile of indomethacin in man","volume":"3","author":"Yeh","year":"1982","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2014.11.010_b0355","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1074\/jbc.270.10.5441","article-title":"Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDR1","volume":"270","author":"Zhang","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2014.11.010_b0360","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0223-5234(02)01360-0","article-title":"A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential","volume":"37","author":"Zhu","year":"2002","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714004382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714004382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:07:52Z","timestamp":1747170472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098714004382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":72,"alternative-id":["S0928098714004382"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2014.11.010","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of fasted state human intestinal fluid as apical solvent system in the Caco-2 absorption model and comparison with FaSSIF","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2014.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}